adriforant (ZPL 3893787) - Novartis
ZPL 389: Regulatory submission for atopic dermatitis in 2022 (Novartis) - Apr 24, 2019 - Q1 2019 Results 
Regulatory
https://www.novartis.com/investors/event-calendar
 
Apr 24, 2019
 
 
a934b614-4919-47e3-9033-81355052b042.jpg